| abstract |
The invention relates to compounds of formula (I) or a salt thereof, wherein R1, R2, R3, R4a, R4b, R4c, R4d, R5, n, and p are defined in the description. The invention also relates to methods of using such compounds as Toll-type 7, or 8, or 9 receptor signaling inhibitors and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of inflammatory and autoimmune diseases. |